Spyridon Makris
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Spyridon Makris has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Cecilia Johansson
Respiratory Infections Section, National Heart and Lung Institute, Imperial College London
9 shared publications - Sophie E. Acton
University College London
5 shared publications - Lydia Durant
Imperial College London
4 shared publications Michelle Goritzka
Respiratory Infections Section, St. Mary's Campus, National Heart and Lung Institute, London, UK
4 shared publicationsCatherine Pereira
Centre for Respiratory Infections, Respiratory Infections Section, St Mary's campus, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, W2 1PG, UK
3 shared publicationsFahima Kausar
National Heart and Lung Institute, Imperial College London, St Mary’s Hospital, Norfolk Place, London, W2 1PG, UK
3 shared publications
Latest Publications
- Open Access
The Extracellular Matrix Regulates Tissue Mechanics to Enable Cyclic Lymph Node Remodelling for Sustained Immunity
Tissue shape and function are defined by the mechanical interactions of cellular and extracellular components. Lymph nodes cyclically remodel in response to immune challenges whilst preserving essential tissue architecture, comprised of a stromal fibroblastic reticular cell (FRC) network and extracellular matrix (ECM) it ensheaths. We experimentally quantified the contribution of ECM to the viscoelastic properties of the FRC network to parameterise an in silico model exploring factors affecting the FRC network's adaptation to lymph node expansion. The balance between tissue pressure, FRC contractility, and ECM stiffness permit robust tissue remodelling, while maintaining physiological geometries. Local perturbation of ECM stiffness or FRC contractility disrupts force distribution and impacts FRC proliferation and tissue expansion. Spatially dispersed perturbations exert higher impact on tissue remodelling than equivalent localised perturbations, with effects propagating across the network. The lymph node provides a system for studying the integration of cellular and extracellular mechanics during dramatic tissue remodelling.
Open AccessThe Extracellular Matrix Regulates Tissue Mechanics to Enable Cyclic Lymph Node Remodelling for Sustained Immunity
Tissue shape and function are defined by the mechanical interactions of cellular and extracellular components. Lymph nodes cyclically remodel in response to immune challenges whilst preserving essential tissue architecture, comprised of a stromal fibroblastic reticular cell (FRC) network and extracellular matrix (ECM) it ensheaths. We experimentally quantified the contribution of ECM to the viscoelastic properties of the FRC network to parameterise an in silico model exploring factors affecting the FRC network's adaptation to lymph node expansion. The balance between tissue pressure, FRC contractility, and ECM stiffness permit robust tissue remodelling, while maintaining physiological geometries. Local perturbation of ECM stiffness or FRC contractility disrupts force distribution and impacts FRC proliferation and tissue expansion. Spatially dispersed perturbations exert higher impact on tissue remodelling than equivalent localised perturbations, with effects propagating across the network. The lymph node provides a system for studying the integration of cellular and extracellular mechanics during dramatic tissue remodelling.
- Open Access
- 15 April 2026
- Published by Elsevier in STAR Protocols
- Vol. 7 (2) , 104501
Protocol for isolating stromal cells from lymphoid tissue for performing scRNA-seq
- 15 April 2026
- Published by Elsevier in STAR Protocols
- Vol. 7 (2) , 104501
Open AccessProtocol for isolating stromal cells from lymphoid tissue for performing scRNA-seq
- Open Access
- 24 January 2022
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 15 (1)
Immune function and dysfunction are determined by lymphoid tissue efficacy
Lymphoid tissue returns to a steady state once each immune response is resolved, and although this occurs multiple times throughout life, its structural integrity and functionality remain unaffected. Stromal cells orchestrate cellular interactions within lymphoid tissue, and any changes to the microenvironment can have detrimental outcomes and drive disease. A breakdown in lymphoid tissue homeostasis can lead to a loss of tissue structure and function that can cause aberrant immune responses. This Review highlights recent advances in our understanding of lymphoid tissue function and remodelling in adaptive immunity and in disease states. We discuss the functional role of lymphoid tissue in disease progression and explore the changes to lymphoid tissue structure and function driven by infection, chronic inflammatory conditions and cancer. Understanding the role of lymphoid tissues in immune responses to a wide range of pathologies allows us to take a fuller systemic view of disease progression.
- 24 January 2022
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 15 (1)
Open AccessImmune function and dysfunction are determined by lymphoid tissue efficacy
Lymphoid tissue returns to a steady state once each immune response is resolved, and although this occurs multiple times throughout life, its structural integrity and functionality remain unaffected. Stromal cells orchestrate cellular interactions within lymphoid tissue, and any changes to the microenvironment can have detrimental outcomes and drive disease. A breakdown in lymphoid tissue homeostasis can lead to a loss of tissue structure and function that can cause aberrant immune responses. This Review highlights recent advances in our understanding of lymphoid tissue function and remodelling in adaptive immunity and in disease states. We discuss the functional role of lymphoid tissue in disease progression and explore the changes to lymphoid tissue structure and function driven by infection, chronic inflammatory conditions and cancer. Understanding the role of lymphoid tissues in immune responses to a wide range of pathologies allows us to take a fuller systemic view of disease progression.
- Open Access
- 1 November 2019
- Published by Elsevier in Cell Reports
- Vol. 29 (9) , 2810-2822.e5
Fibroblastic Reticular Cells Control Conduit Matrix Deposition during Lymph Node Expansion
- 1 November 2019
- Published by Elsevier in Cell Reports
- Vol. 29 (9) , 2810-2822.e5
Open AccessFibroblastic Reticular Cells Control Conduit Matrix Deposition during Lymph Node Expansion
- Open Access
- 29 July 2019
- Published by Elsevier in Mucosal Immunology
- Vol. 12 (5) , 1244-1255
Neutrophil recruitment and activation are differentially dependent on MyD88/TRIF and MAVS signaling during RSV infection
- 29 July 2019
- Published by Elsevier in Mucosal Immunology
- Vol. 12 (5) , 1244-1255
Open AccessNeutrophil recruitment and activation are differentially dependent on MyD88/TRIF and MAVS signaling during RSV infection
- Open Access
- 1 July 2019
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 144 (1) , 342-345.e7
Induction of innate cytokine responses by respiratory mucosal challenge with R848 in zebrafish, mice, and humans
- 1 July 2019
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 144 (1) , 342-345.e7
Open AccessInduction of innate cytokine responses by respiratory mucosal challenge with R848 in zebrafish, mice, and humans
- 4 February 2019
- Published by H1 Connect
- Vol. 198 (8)
Faculty Opinions recommendation of Infant Viral Respiratory Infection Nasal Immune-Response Patterns and Their Association with Subsequent Childhood Recurrent Wheeze.
RATIONALE: Recurrent wheeze and asthma are thought to result from alterations in early life immune development following respiratory syncytial virus (RSV) infection. However, prior studies of the nasal immune response to infection have assessed only individual cytokines, which does not capture the whole spectrum of response to infection. OBJECTIVES: To identify nasal immune phenotypes in response to RSV infection and their association with recurrent wheeze. METHODS: A birth cohort of term healthy infants born June to December were recruited and followed to capture the first infant RSV infection. Nasal wash samples were collected during acute respiratory infection, viruses were identified by RT-PCR, and immune-response analytes were assayed using a multianalyte bead-based panel. Immune-response clusters were identified using machine learning, and association with recurrent wheeze at age 1 and 2 years was assessed using logistic regression. MEASUREMENTS AND MAIN RESULTS: We identified two novel and distinct immune-response clusters to RSV and human rhinovirus. In RSV-infected infants, a nasal immune-response cluster characterized by lower non-IFN antiviral immune-response mediators, and higher type-2 and type-17 cytokines was significantly associated with first and second year recurrent wheeze. In comparison, we did not observe this in infants with human rhinovirus acute respiratory infection. Based on network analysis, type-2 and type-17 cytokines were central to the immune response to RSV, whereas growth factors and chemokines were central to the immune response to human rhinovirus. CONCLUSIONS: Distinct immune-response clusters during infant RSV infection and their association with risk of recurrent wheeze provide insights into the risk factors for and mechanisms of asthma development.
- 4 February 2019
- Published by H1 Connect
- Vol. 198 (8)
Faculty Opinions recommendation of Infant Viral Respiratory Infection Nasal Immune-Response Patterns and Their Association with Subsequent Childhood Recurrent Wheeze.
RATIONALE: Recurrent wheeze and asthma are thought to result from alterations in early life immune development following respiratory syncytial virus (RSV) infection. However, prior studies of the nasal immune response to infection have assessed only individual cytokines, which does not capture the whole spectrum of response to infection. OBJECTIVES: To identify nasal immune phenotypes in response to RSV infection and their association with recurrent wheeze. METHODS: A birth cohort of term healthy infants born June to December were recruited and followed to capture the first infant RSV infection. Nasal wash samples were collected during acute respiratory infection, viruses were identified by RT-PCR, and immune-response analytes were assayed using a multianalyte bead-based panel. Immune-response clusters were identified using machine learning, and association with recurrent wheeze at age 1 and 2 years was assessed using logistic regression. MEASUREMENTS AND MAIN RESULTS: We identified two novel and distinct immune-response clusters to RSV and human rhinovirus. In RSV-infected infants, a nasal immune-response cluster characterized by lower non-IFN antiviral immune-response mediators, and higher type-2 and type-17 cytokines was significantly associated with first and second year recurrent wheeze. In comparison, we did not observe this in infants with human rhinovirus acute respiratory infection. Based on network analysis, type-2 and type-17 cytokines were central to the immune response to RSV, whereas growth factors and chemokines were central to the immune response to human rhinovirus. CONCLUSIONS: Distinct immune-response clusters during infant RSV infection and their association with risk of recurrent wheeze provide insights into the risk factors for and mechanisms of asthma development.
- Open Access
- 24 September 2018
- Published by F1000 Research Ltd in F1000Research
- Vol. 7, 1537
Recent advances in understanding rhinovirus immunity
Rhinoviruses are the most common cause of upper respiratory tract infections. However, they can induce exacerbations of chronic obstructive pulmonary disease and asthma, bronchiolitis in infants, and significant lower respiratory tract infections in children, the immunosuppressed, and the elderly. The large number of rhinovirus strains (currently about 160) and their antigenic diversity are significant obstacles in vaccine development. The phenotype of immune responses induced during rhinovirus infection can affect disease severity. Recognition of rhinovirus and a balance of innate responses are important factors in rhinovirus-induced morbidity. Immune responses to rhinovirus infections in healthy individuals are typically of the T helper type 1 (Th1) phenotype. However, rhinovirus-driven asthma exacerbations are additionally characterised by an amplified Th2 immune response and airway neutrophilia. This commentary focuses on recent advances in understanding immunity toward rhinovirus infection and how innate and adaptive immune responses drive rhinovirus-induced asthma exacerbations.
- 24 September 2018
- Published by F1000 Research Ltd in F1000Research
- Vol. 7, 1537
Open AccessRecent advances in understanding rhinovirus immunity
Rhinoviruses are the most common cause of upper respiratory tract infections. However, they can induce exacerbations of chronic obstructive pulmonary disease and asthma, bronchiolitis in infants, and significant lower respiratory tract infections in children, the immunosuppressed, and the elderly. The large number of rhinovirus strains (currently about 160) and their antigenic diversity are significant obstacles in vaccine development. The phenotype of immune responses induced during rhinovirus infection can affect disease severity. Recognition of rhinovirus and a balance of innate responses are important factors in rhinovirus-induced morbidity. Immune responses to rhinovirus infections in healthy individuals are typically of the T helper type 1 (Th1) phenotype. However, rhinovirus-driven asthma exacerbations are additionally characterised by an amplified Th2 immune response and airway neutrophilia. This commentary focuses on recent advances in understanding immunity toward rhinovirus infection and how innate and adaptive immune responses drive rhinovirus-induced asthma exacerbations.
- 18 September 2018
- Published by H1 Connect
Faculty Opinions recommendation of Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma.
T helper type 2 (Th2) immune responses are characterized by increased production of interleukin (IL)-4, IL-5, and IL-13 and have been associated with rhinovirus infection in asthma. Cytokines inducing Th2 responses provide a potential therapeutic target. In this study, dupilumab (IL-4 and IL-13 signaling inhibitor) significantly reduced the rates of severe asthma exacerbations and improved lung function in patients. This Recommendation is of an article referenced in an F1000 Faculty Review also written by Spyridon Makris and Sebastian Johnston.
- 18 September 2018
- Published by H1 Connect
Faculty Opinions recommendation of Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma.
T helper type 2 (Th2) immune responses are characterized by increased production of interleukin (IL)-4, IL-5, and IL-13 and have been associated with rhinovirus infection in asthma. Cytokines inducing Th2 responses provide a potential therapeutic target. In this study, dupilumab (IL-4 and IL-13 signaling inhibitor) significantly reduced the rates of severe asthma exacerbations and improved lung function in patients. This Recommendation is of an article referenced in an F1000 Faculty Review also written by Spyridon Makris and Sebastian Johnston.